Egypt Aminoglycosides Market (2025-2031) | Outlook, Share, Revenue, Forecast, Analysis, Companies, Value, Industry, Trends, Size & Growth

Market Forecast By Product (Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Streptomycin, Kanamycin, Others), By Route of Administration (Injectables (Parenteral), Feed, Intra-mammary, Topical, Oral), By Application (Veterinary, Skin Infection, Respiratory diseases, UTI & Pelvic Diseases, Other diseases) And Competitive Landscape

Product Code: ETC312112 Publication Date: Aug 2022 Updated Date: Aug 2025 Product Type: Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 5

Egypt Aminoglycosides Market Highlights

Report Name Egypt Aminoglycosides Market 
Forecast period 2025-2031
CAGR 4.6%
Growing Sector Healthcare

Topics Covered in the Egypt Aminoglycosides Market Report

Egypt Aminoglycosides Market report thoroughly covers the market by product, by route of administration, and by application. The market outlook report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.

Egypt Aminoglycosides Market Synopsis

The Egypt aminoglycosides market is expected to witness significant growth in the coming years due to the rising prevalence of infectious diseases and increasing demand for effective antibiotics. Aminoglycosides are a class of potent antibiotics used to treat severe bacterial infections, including tuberculosis and multidrug-resistant bacteria. These drugs are known for their broad-spectrum activity against a wide range of gram-negative bacteria.

According to 6Wresearch, the Egypt Aminoglycosides Market size is estimated to grow at a CAGR of 4.6% during the forecast period 2025-2031. The increasing prevalence of infectious diseases and the rise of multidrug-resistant bacteria are the major factors driving the growth of the market. Moreover, the growing demand for effective antibiotics and advancements in technology for drug development have also contributed to market growth. However, the high cost of aminoglycoside antibiotics and the availability of alternative treatment options may hinder market growth in Egypt. The Egypt aminoglycosides industry is witnessing several trends that are expected to create new opportunities for existing players and potential entrants. One such trend is the increasing focus on developing novel aminoglycoside antibiotics with improved efficacy and reduced side effects. Additionally, the introduction of combination therapies, where aminoglycosides are used in conjunction with other classes of antibiotics, is also gaining traction in the market.

Government Initiatives Introduced in the Egypt Aminoglycosides Market

The Egyptian government has introduced several initiatives to enhance the aminoglycosides market. These measures include increased funding for antibiotic research, optimizing the regulatory process for antibiotic approval, and implementing stringent guidelines to curb antibiotic resistance. The government also promotes awareness campaigns about the prudent use of antibiotics among healthcare professionals and the public.

Key Players in the Egypt Aminoglycosides Market

There are several key players in the Egypt aminoglycosides market, including local and international pharmaceutical companies. Some of the major players include Pfizer Inc., Novartis International AG, Sanofi S.A., and GlaxoSmithKline plc. Furthermore, local pharmaceutical companies such as Eva Pharma, Amoun Pharmaceutical Company S.A.E., and Pharco Pharmaceuticals are also important players in the Egypt aminoglycosides market.

Future Insights of the Egypt Aminoglycosides Market

The Egypt aminoglycosides market growth is poised to evolve with technological advancements and increased government intervention. The development of new antibiotics that are more effective against resistant bacteria, combined with improvements in diagnostic testing, will likely drive further growth. In addition, the strategic expansion of key players into emerging markets and the potential for public-private partnerships hold promising prospects for the future of this market.

Market Analysis by Product

According to Dhaval, Research Manager, 6Wresearch, Neomycin is currently the only product demonstrating significant growth. Neomycin's rise in popularity can be attributed to its efficacy in treating a broad range of bacterial infections, as well as its relative affordability compared to other aminoglycosides.

Market Analysis by Application

Based on the application, the veterinary sector is expected to be the only application area of aminoglycosides that will continue to see growth in the Egypt market. This can be attributed to increasing concerns over animal health and welfare, leading to higher demand for effective antibiotic treatments.

Key attractiveness of the report

  • 10 Years Market Numbers.
  • Historical Data Starting from 2021 to 2024.
  • Base Year: 2024.
  • Forecast Data until 2031.
  • Key Performance Indicators Impacting the Market.
  • Major Upcoming Developments and Projects.

Key Highlights of the Report:

  • Egypt Aminoglycosides Market Outlook
  • Market Size of Egypt Aminoglycosides Market, 2024
  • Forecast of Egypt Aminoglycosides Market, 2031
  • Historical Data and Forecast of Egypt Aminoglycosides Revenues & Volume for the Period 2021 - 2031
  • Egypt Aminoglycosides Market Trend Evolution
  • Egypt Aminoglycosides Market Drivers and Challenges
  • Egypt Aminoglycosides Price Trends
  • Egypt Aminoglycosides Porter's Five Forces
  • Egypt Aminoglycosides Industry Life Cycle
  • Historical Data and Forecast of Egypt Aminoglycosides Market Revenues & Volume By Product for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt Aminoglycosides Market Revenues & Volume By Neomycin for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt Aminoglycosides Market Revenues & Volume By Tobramycin for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt Aminoglycosides Market Revenues & Volume By Gentamicin for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt Aminoglycosides Market Revenues & Volume By Amikacin for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt Aminoglycosides Market Revenues & Volume By Paromomycin for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt Aminoglycosides Market Revenues & Volume By Streptomycin for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt Aminoglycosides Market Revenues & Volume By Kanamycin for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt Neomycin Aminoglycosides Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt Aminoglycosides Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt Aminoglycosides Market Revenues & Volume By Injectables (Parenteral) for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt Aminoglycosides Market Revenues & Volume By Feed for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt Aminoglycosides Market Revenues & Volume By Intra-mammary for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt Aminoglycosides Market Revenues & Volume By Topical for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt Aminoglycosides Market Revenues & Volume By Oral for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt Aminoglycosides Market Revenues & Volume By Application for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt Aminoglycosides Market Revenues & Volume By Veterinary for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt Aminoglycosides Market Revenues & Volume By Skin Infection for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt Aminoglycosides Market Revenues & Volume By Respiratory diseases for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt Aminoglycosides Market Revenues & Volume By UTI & Pelvic Diseases for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt Aminoglycosides Market Revenues & Volume By Other diseases for the Period 2021 - 2031
  • Egypt Aminoglycosides Import Export Trade Statistics
  • Market Opportunity Assessment By Product
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By Application
  • Egypt Aminoglycosides Top Companies Market Share
  • Egypt Aminoglycosides Competitive Benchmarking By Technical and Operational Parameters
  • Egypt Aminoglycosides Company Profiles
  • Egypt Aminoglycosides Key Strategic Recommendations

Market Covered

The report offers a comprehensive study of the subsequent market segments:

By Product

  • Neomycin
  • Tobramycin
  • Gentamicin
  • Amikacin
  • Paromomycin
  • Streptomycin
  • Kanamycin
  • Others

By Route Of Administration

  • Injectables (Parenteral)
  • Feed
  • Intra-Mammary
  • Topical
  • Oral

By Application

  • Veterinary
  • Skin Infection
  • Respiratory Diseases
  • UTI & Pelvic Diseases
  • Other Diseases

Egypt Aminoglycosides Market (2025-2031): FAQs

The rising incidence of infectious diseases, advancements in technology and research, and increased healthcare spending are some key factors of the market.
The veterinary sector is leading in the market with increasing concerns over animal health and welfare, leading to higher demand for effective antibiotic treatments.
Some of the major players include Pfizer Inc., Novartis International AG, Sanofi S.A., and GlaxoSmithKline plc.
6Wresearch actively monitors the Egypt Aminoglycosides Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the Egypt Aminoglycosides Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
1 Executive Summary
2 Introduction
2.1 Key Highlights of the Report
2.2 Report Description
2.3 Market Scope & Segmentation
2.4 Research Methodology
2.5 Assumptions
3 Egypt Aminoglycosides Market Overview
3.1 Egypt Country Macro Economic Indicators
3.2 Egypt Aminoglycosides Market Revenues & Volume, 2021 & 2031F
3.3 Egypt Aminoglycosides Market - Industry Life Cycle
3.4 Egypt Aminoglycosides Market - Porter's Five Forces
3.5 Egypt Aminoglycosides Market Revenues & Volume Share, By Product, 2021 & 2031F
3.6 Egypt Aminoglycosides Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F
3.7 Egypt Aminoglycosides Market Revenues & Volume Share, By Application, 2021 & 2031F
4 Egypt Aminoglycosides Market Dynamics
4.1 Impact Analysis
4.2 Market Drivers
4.2.1 Increasing prevalence of bacterial infections in Egypt
4.2.2 Growing awareness about the effectiveness of aminoglycosides in treating infections
4.2.3 Rise in healthcare expenditure and infrastructure development in Egypt
4.3 Market Restraints
4.3.1 Stringent regulatory requirements for aminoglycosides approval and usage
4.3.2 Potential side effects and toxicity associated with aminoglycosides
4.3.3 Competition from alternative antibiotics and antimicrobial agents
5 Egypt Aminoglycosides Market Trends
6 Egypt Aminoglycosides Market, By Types
6.1 Egypt Aminoglycosides Market, By Product
6.1.1 Overview and Analysis
6.1.2 Egypt Aminoglycosides Market Revenues & Volume, By Product, 2021 - 2031F
6.1.3 Egypt Aminoglycosides Market Revenues & Volume, By Neomycin, 2021 - 2031F
6.1.4 Egypt Aminoglycosides Market Revenues & Volume, By Tobramycin, 2021 - 2031F
6.1.5 Egypt Aminoglycosides Market Revenues & Volume, By Gentamicin, 2021 - 2031F
6.1.6 Egypt Aminoglycosides Market Revenues & Volume, By Amikacin, 2021 - 2031F
6.1.7 Egypt Aminoglycosides Market Revenues & Volume, By Paromomycin, 2021 - 2031F
6.1.8 Egypt Aminoglycosides Market Revenues & Volume, By Streptomycin, 2021 - 2031F
6.1.9 Egypt Aminoglycosides Market Revenues & Volume, By Others, 2021 - 2031F
6.1.10 Egypt Aminoglycosides Market Revenues & Volume, By Others, 2021 - 2031F
6.2 Egypt Aminoglycosides Market, By Route of Administration
6.2.1 Overview and Analysis
6.2.2 Egypt Aminoglycosides Market Revenues & Volume, By Injectables (Parenteral), 2021 - 2031F
6.2.3 Egypt Aminoglycosides Market Revenues & Volume, By Feed, 2021 - 2031F
6.2.4 Egypt Aminoglycosides Market Revenues & Volume, By Intra-mammary, 2021 - 2031F
6.2.5 Egypt Aminoglycosides Market Revenues & Volume, By Topical, 2021 - 2031F
6.2.6 Egypt Aminoglycosides Market Revenues & Volume, By Oral, 2021 - 2031F
6.3 Egypt Aminoglycosides Market, By Application
6.3.1 Overview and Analysis
6.3.2 Egypt Aminoglycosides Market Revenues & Volume, By Veterinary, 2021 - 2031F
6.3.3 Egypt Aminoglycosides Market Revenues & Volume, By Skin Infection, 2021 - 2031F
6.3.4 Egypt Aminoglycosides Market Revenues & Volume, By Respiratory diseases, 2021 - 2031F
6.3.5 Egypt Aminoglycosides Market Revenues & Volume, By UTI & Pelvic Diseases, 2021 - 2031F
6.3.6 Egypt Aminoglycosides Market Revenues & Volume, By Other diseases, 2021 - 2031F
7 Egypt Aminoglycosides Market Import-Export Trade Statistics
7.1 Egypt Aminoglycosides Market Export to Major Countries
7.2 Egypt Aminoglycosides Market Imports from Major Countries
8 Egypt Aminoglycosides Market Key Performance Indicators
8.1 Antibiotic resistance rates in Egypt
8.2 Number of new product launches or approvals in the aminoglycosides segment
8.3 Investment in research and development for aminoglycosides innovation
8.4 Number of healthcare facilities adopting aminoglycosides as a preferred treatment option
8.5 Patient adherence and compliance rates to aminoglycosides therapy
9 Egypt Aminoglycosides Market - Opportunity Assessment
9.1 Egypt Aminoglycosides Market Opportunity Assessment, By Product, 2021 & 2031F
9.2 Egypt Aminoglycosides Market Opportunity Assessment, By Route of Administration, 2021 & 2031F
9.3 Egypt Aminoglycosides Market Opportunity Assessment, By Application, 2021 & 2031F
10 Egypt Aminoglycosides Market - Competitive Landscape
10.1 Egypt Aminoglycosides Market Revenue Share, By Companies, 2024
10.2 Egypt Aminoglycosides Market Competitive Benchmarking, By Operating and Technical Parameters
11 Company Profiles
12 Recommendations
13 Disclaimer
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All